Search
Anavex Life Sciences Corp
AVXLAdd to Watchlist
2.560USD
-0.020-0.78%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
237.24MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-24The current earnings forecast score of Anavex Life Sciences Corp is 8.00, ranking 167 out of 388 in the Biotechnology & Medical Research industry. The average price target is 22.00, with a high of 24.00 and a low of 20.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
20.000
Target Price
+632.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Anavex Life Sciences Corp
AVXL
1
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Anavex Life Sciences Corp's price target?
Analysts forecast that Anavex Life Sciences Corp's price target is USD 22.00, with the highest forecast at USD 24.00 and the lowest forecast at USD 20.00.
How have Anavex Life Sciences CorpAVXL's recent earnings per share performed?
The market expectation was USD -0.06, while Anavex Life Sciences CorpAVXL's earnings per share (EPS) for the previous quarter was USD -0.11. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Anavex Life Sciences Corp?
Based on the ratings of Anavex Life Sciences Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
